This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
10 results for: cbd
post featured image

Cannabis remains a controlled substance in most jurisdictions, but demand for medicinal and wellbeing cannabis products and their...

post featured image

On 15 December 2020, the Australian Therapeutic Goods Administration (TGA) published its decision to down-schedule certain low dose...

post featured image

As the legal landscape for hemp continues to evolve, manufacturers and sellers of CBD products face increased challenges, such as an...

post featured image

The Court of Justice of the European Union (CJEU) has ruled that EU Member States cannot prohibit the marketing of cannabidiol (CBD)...

post featured image

The UK FSA's announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the...

post featured image

We previously reported in our article “Developments in Australian CBD market” that the Pharmaceutical Benefits Advisory Committee (PBAC)...

post featured image

The Australian Government has moved to further bolster the local cannabis industry with the passing of the Export Control Legislation...

post featured image

The cannabidiol (CBD) medicine market in Australia is set to grow. At present, there are no medicinal CBD products registered on the...

post featured image

The Therapeutic Goods Administration (TGA) – Australia’s regulatory body for pharmaceuticals and medical devices – is proposing to...

post featured image

By Rahool Sarjua and Kahwing Fung, 13 February 2020

2019 was a big year for cannabidiol (CBD) based products with new products appearing...